"I think until there is good widespread familiarity and feedback about Reloxin, there will always be those who cling to the 'tried and true.' Contrarily, there are always those who jump on the bandwagon of the next new product," said Dr. Carl Washington, associate professor of dermatology at the Emory Clinic in Atlanta.
Furthermore, while cost may be a concern for patients, it doesn't seem to be altering their behavior.
"I cannot think of an instance where a patient declined Botox due to its cost," Washington said.
Still, there is always the possibility that there may be newcomers to the skin injection scene.
"If [Reloxin] is cost-effective for the same results, then it will carve out a specific niche in that marketplace," Singer said. "I think that among physicians who are well-trained, board-certified plastic surgeons and dermatologists, many will offer both. People like menus of options. Of course, all of these things only time will tell."
But would a dedicated Botox fan, like Jennifer, actually switch to a less costly alternative?
"The only way I would consider it would be if Dr. Placik recommended it," said Jennifer.
Placik, in turn, said his bottom-line consideration is equally simple: "What is the patient going to ask for?"